EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC-ND 4.0

Recent advances in hepatitis E virus research and the Japanese clinical practice guidelines for hepatitis E virus infection

Tatsuo Kanda iD, Tian-Cheng Li iD, Masaharu Takahashi iD, Shigeo Nagashima iD, Putu Prathiwi Primadharsini iD, Satoshi Kunita iD, Reina Sasaki-Tanaka iD, Jun Inoue iD, Atsunori Tsuchiya iD, Shingo Nakamoto iD, Ryuzo Abe iD, Keiichi Fujiwara iD und 6 weitere

Hepatology Research · 2024-08 · 54 (8) · 1-30

DOI: 10.1111/hepr.14062 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Hepatology Research, online erschienen am 14.06.2024. Verfasst von Tatsuo Kanda und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 383 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute hepatitis E was considered rare until reports emerged affirming the existence of hepatitis E virus (HEV) genotypes 3 and 4 infections in Japan in the early 2000s. Extensive studies by Japanese researchers have highlighted the pivotal role of pigs and wild animals, such as wild boars and deer, as reservoirs for HEV, linking them to zoonotic infections in Japan. Currently, when hepatitis occurs subsequent to the consumption of undercooked or grilled pork, wild boar meat, or offal (including pig liver and intestines), HEV infection should be considered. Following the approval of anti‐HEV immunoglobulin A antibody as a diagnostic tool for hepatitis E by Japan's Health Insurance System in 2011, the annual number of diagnosed cases of HEV infection has surged. Notably, the occurrence of post‐transfusion hepatitis E promoted nationwide screening of blood products for HEV using nucleic acid amplification tests since 2020. Furthermore, chronic hepatitis E has been observed in immunosuppressed individuals. Considering the significance of hepatitis E, heightened preventive measures are essential. The Japan Agency for Medical Research and Development Hepatitis A and E viruses (HAV and HEV) Study Group, which includes special virologists and hepatologists, held a virtual meeting on February 17, 2024. Discussions encompassed pathogenesis, transmission routes, diagnosis, complications, severity factors, and ongoing and prospective vaccination or treatments for hepatitis E. Rigorous assessment of referenced studies culminated in the formulation of recommendations, which are detailed within this review. This comprehensive review presents recent advancements in HEV research and Japanese clinical practice guidelines for HEV infection.

Schlagwörter

Stichwörter der Autor:innen

Japan Agency for Medical Research and Developmentchronic infectioncurrent and future researchguidelinehepatitis E virus

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
  • Division of Gastroenterology and Hepatology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Minamiuonuma, Japan.
  • Division of Gastroenterology and Hepatology, Graduate School of Medicine and Dental Sciences, Niigata University, Niigata, Japan.
  • Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
  • Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine, Shimotsuke, Tochigi, Japan.
  • Center for Experimental Medicine, Jichi Medical University School of Medicine, Shimotsuke, Tochigi, Japan.

ORCID-Profile: Tatsuo Kanda, Tian-Cheng Li, Masaharu Takahashi, Shigeo Nagashima, Putu Prathiwi Primadharsini, Satoshi Kunita, Reina Sasaki-Tanaka, Jun Inoue, Atsunori Tsuchiya, Shingo Nakamoto, Ryuzo Abe, Keiichi Fujiwara, Osamu Yokosuka, Ryosuke Suzuki, Koji Ishii, Hiroshi Yotsuyanagi, Hiroaki Okamoto

Förderung

  • The Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development

Zitieren

APA

Kanda, T., Li, T. C., Takahashi, M., Nagashima, S., Primadharsini, P. P., Kunita, S., Sasaki-Tanaka, R., Inoue, J., Tsuchiya, A., Nakamoto, S., Abe, R., Fujiwara, K., Yokosuka, O., Suzuki, R., Ishii, K., Yotsuyanagi, H., Okamoto, H., & AMED HAV and HEV Study Group (2024). Recent advances in hepatitis E virus research and the Japanese clinical practice guidelines for hepatitis E virus infection. Hepatology Research, 54(8), 1-30. https://doi.org/10.1111/hepr.14062

Vancouver

Kanda T, Li TC, Takahashi M, Nagashima S, Primadharsini PP, Kunita S, et al. Recent advances in hepatitis E virus research and the Japanese clinical practice guidelines for hepatitis E virus infection. Hepatology Research. 2024;54(8):1-30. doi:10.1111/hepr.14062

BibTeX
@article{Kanda2024,
  author = {Kanda, Tatsuo and Li, Tian-Cheng and Takahashi, Masaharu and Nagashima, Shigeo and Primadharsini, Putu Prathiwi and Kunita, Satoshi and Sasaki-Tanaka, Reina and Inoue, Jun and Tsuchiya, Atsunori and Nakamoto, Shingo and Abe, Ryuzo and Fujiwara, Keiichi and Yokosuka, Osamu and Suzuki, Ryosuke and Ishii, Koji and Yotsuyanagi, Hiroshi and Okamoto, Hiroaki and AMED HAV and HEV Study Group, AMED HAV and HEV Study Group},
  title = {Recent advances in hepatitis E virus research and the Japanese clinical practice guidelines for hepatitis E virus infection},
  journal = {Hepatology Research},
  year = {2024},
  volume = {54},
  number = {8},
  pages = {1--30},
  doi = {10.1111/hepr.14062}
}
Kostenlos starten →